Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions. - Wikidata - awgldk - TriplyDB

Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.

Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.

http://www.wikidata.org/entity/Q34382719

about

Recent updates of precision therapy for gastric cancer: Towards optimal tailored management The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair Is NEDD4-1 a negative regulator of phosphatase and tensin homolog in gastric carcinogenesis?Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.Airway PI3K pathway activation is an early and reversible event in lung cancer development.Cause and consequences of genetic and epigenetic alterations in human cancer.Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review).Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.Pseudogenes in gastric cancer pathogenesis: a review article.Allelic loss at PTEN locus leads to progression of colorectal carcinoma among North Indian patients.Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.Mechanism of apoptosis involved in gastric mucosal lesions in Tibetans with high-altitude polycythemia.Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas.Microsatellite Alterations and Protein Expression of 5 Major Tumor Suppressor Genes in Gastric Adenocarcinomas.

P2860

Q26746246-63D00F10-E9C5-4731-9F16-E21C2B766227 Q27852562-A1DA5F5B-566E-47C1-879D-1988B5BD2132 Q33480141-9EB01C2E-790A-4039-B59B-F3FC4AE2D4FA Q34481443-7BCD6123-094D-4108-9958-D562088A217B Q36410440-DB4BF3D8-7304-4B1A-B926-9C222EADE3E1 Q36713134-A3075D6C-56B7-48D4-ADC8-3D9675B57A38 Q36959707-9F5D5E17-48B8-406D-B468-8A2FD4DC30D6 Q37511752-58024BC0-55FF-4B4C-AC54-3600F8EE775F Q37567784-CCEC2848-E5FE-4D10-9CE6-A880A8DBF47A Q38242086-D2459684-51F7-4A1D-BA49-D074209C0172 Q38696613-BF915929-6F20-478D-AEA3-C8E505D9D777 Q39275455-39BF5A9F-DC7A-4DA7-8D34-A74D0C1F07A3 Q39836086-9EEFA940-3814-4963-B123-2A4570AB5419 Q41356993-F04ACFB5-DB46-4CC9-A78E-04F2300CBA2C Q42376301-84C437F1-CA4C-4AE5-BA67-961F5155684F Q43861270-25340584-63FB-4BC7-99F2-43B72947995F Q47152852-FFC18E47-DA2C-4B6C-B342-52F65A6BB661

P2860

Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions.

http://www.wikidata.org/entity/Q34382719

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@ast

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@en

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@nl

type

label

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@ast

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@en

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@nl

prefLabel

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@ast

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@en

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@nl

P1433

Q34382719-A4930177-4A19-4B01-A673-C37335CC83B0

P1476

Q34382719-14974F53-259C-422F-93C7-2BAE3DA4A426

P2093

Q34382719-18C8C56B-987E-4FE0-9B98-481B3971948C

Q34382719-595C7D63-0458-45B6-A490-C017D7813740

Q34382719-97481027-5A00-4077-AFFD-52A6A9EFCDED

Q34382719-CDA8796E-7E28-4F99-B929-2C785AB105BD

Q34382719-F177D4C9-CA8C-4202-90A1-8D33B620B290

P2860

Q34382719-09AFD3A3-C4A7-4EED-B122-AC1E6B69D3D8

Q34382719-12A422B8-8DC1-4C36-A0FE-B457672F42F1

Q34382719-1413B856-5C26-4E17-92CC-84B753EE6D4B

Q34382719-154190ED-7156-48D2-A550-E9E1CD5B393C

Q34382719-28FDA3EE-F134-49DE-9556-F142E491F4CF

Q34382719-3B8D570A-EBEE-487D-BF62-C5726D221AF8

Q34382719-5891A61F-03E9-4321-BA9B-ECB8958EEA92

Q34382719-6C5DAA05-40B6-469E-B8C3-355363A67D61

Q34382719-859503E9-274E-4800-AFDA-F4512F0A5E95

Q34382719-88D4890E-A264-46CF-9873-05823400628F

P304

Q34382719-FFF77C18-A3FA-491E-AD72-6866DA46CFC9

P31

Q34382719-83D01125-B023-4AF7-9B9C-AC274E8763E2

P356

Q34382719-22A841D1-7200-4A24-A7EC-115B418A7428

P407

Q34382719-9A5487AF-8EFA-4357-8801-7890B7CA3525

P433

Q34382719-6A27DC71-44F3-40E5-A634-815B1CFD3C90

P478

Q34382719-D2D232F0-4F37-4597-9D10-5498BA1E62C0

P577

Q34382719-9F37E332-4BD6-4C68-85CF-E1F8B46A3DC0

P5875

Q34382719-FAC3597F-3C8E-40DB-A37C-8073F25400AF

P698

Q34382719-33572BD5-117B-4D18-B857-8C0C597D8F03

P932

Q34382719-02F08C01-2E0C-4696-9413-1605A5C00B7D

P356

P1433

World Journal of Gastroenterology

P1476

Loss of heterozygosity on 10q2 ...... ncer and precancerous lesions.

@en

P2093

Bao-Yu Fu

http://www.w3.org/2001/XMLSchema#string

Dong-Ying Wu

http://www.w3.org/2001/XMLSchema#string

Yan Xin

http://www.w3.org/2001/XMLSchema#string

Yi-Ling Li

http://www.w3.org/2001/XMLSchema#string

Zhong Tian

http://www.w3.org/2001/XMLSchema#string

P2860

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids

PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease

Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase

The mechanism of action of the tumour suppressor gene PTEN

Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN.

Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.

Common genetic changes between endometriosis and ovarian cancer.

Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.

Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling.

P304

285-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I2.285

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8098212

http://www.w3.org/2001/XMLSchema#string

P698

15633233

http://www.w3.org/2001/XMLSchema#string

P932

4205419

http://www.w3.org/2001/XMLSchema#string